期刊文献+

一例伴有低亚二倍体异常的多发性骨髓瘤的临床和实验研究 被引量:1

Clinical and experimental study of a multiple myeloma case with low hypodiploidy
原文传递
导出
摘要 目的报告1例伴有低亚二倍体复杂异常的多发性骨髓瘤病例并探讨其临床和实验室特点。方法采用骨髓细胞短期培养法制备染色体,用R显带技术进行核型分析。用13q14、p53、Rb1、1q21一系列单色探针和IgH/CCND1双色双融合探针对其进行荧光原位杂交检测。用流式细胞仪检测DNA含量。结果R显带核型分析提示该患者5个细胞为包含35条染色体的低亚二倍体核型,3个细胞为低亚二倍体克隆的复制,另外4个细胞为正常核型。间期荧光原位杂交证实核型中存在1号、13号、14号、17号染色体单体,且显示mar1来源于11号染色体并造成CCND1基因的扩增。流式细胞仪检测DNA含量显示其有低亚二倍体克隆峰,DNA指数为0.8426。结论低亚二倍体核型在多发性骨髓瘤中发生率极低,荧光原位杂交技术是检测多发性骨髓瘤分子异常的可靠手段。 Objective To report the clinical and laboratory characterization of a case of multiple myeloma with low hypodiploid complex karyotyptic abnormalities. Methods Cytogenetic examination of bone marrow performed by 24 h culture method. R-banding technique was used to analyze the karyotype. Interphase fluorescence in situ hybridization (FISH) was performed using chromosome probes such as 13q14,p53, Rbl, lq21 and IgH/CCND1. The DNA content was detected by flow cytometry. Results Chromosome analysis revealed complex chromosomal rearrangement. Five cells had a low hypodiploid karyotype with chromosomal number 35. Three ceils had the duplication of the low hypodiploid karyotype. Four cells had normal karyotype. Monosomy 1, 13,14 , 17 and the mark chromosome 1 derivated from chromosome 11 resulting in the amplication of CCND1 gene were confirmed by interphase FISH. Flow cytometric analysis displayed a low hypodiploid peak with the DNA index of 0. 8426. Conclusion These results indicated that the low hypodiploidy is a rare abnormality in multiple myeloma. Interphase FISH is a reliable method for detecting molecular abnormalities in multiple myeloma.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2012年第3期343-346,共4页 Chinese Journal of Medical Genetics
基金 基金项目:苏州市“科教兴卫”青年科技项目(SWKQ0901)
关键词 多发性骨髓瘤 低亚二倍体 荧光原位杂交 Multiple myeloma Low hypodiploid Fluorescence in situ hybridization
  • 相关文献

参考文献9

  • 1Mahindra biology of Seong C, A, Hideshima T, Anderson KC. Multiple myeloma the disease. Blood Rev,2010,24(Suppl 1) :S5-11.
  • 2Seong C, Delasalle K, Hayes K, et al. Prognostic value of cytogenetics in muhiple myeloma. Br J Haematol, 1998,101 : 189- 194.
  • 3Lai JL, Zandecki M, Mary JY, et al. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 1995,85 : 2490-2497.
  • 4Smadja NV, Bastard C, Brigaudeau C, et al. Hypodiploidy is a major prognostic factor in multiple myeloma. Blood, 2001,98: 2229-2238.
  • 5An International System for Human Cytogenotic Nomenclature (ed. By F. Mitelman). Karger,Basel. ISCN(2009).
  • 6Moorman AV, Harrison CJ, Buck GAN, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/ Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 2007,109 : 3189-3197.
  • 7Moorman AV, Ensor HM, Richards SM, et al. Results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol, 2010,11 :429-438.
  • 8Harrison CJ, Moorman AV, Broadfield ZJ, et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol, 2004,125:552-559.
  • 9Hoechtlen-Vollmar W, Menzel G, Bartl R, et al. Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance. Br J Haematol,2000,109 : 30-38.

同被引文献11

  • 1International Standing Committee on Human Cytoge netie Nomenclature, Shaffer LG,Tommerup N. An in ternational system for human cytogenetic nomencla ture[M]. S: BKarger AG, 2005.
  • 2Palumbo A, Anderson K . Multiple myeloma[J]. N Engl J Med,2011,364(11) :1046-1060.
  • 3Gonzdlez D,van der Burg M,Garcia-Sanz R,et al. Im- munoglobulin gene rearrangements and the pathogen- esis of multiple myeloma[J]. Blood, 2007, 110 (9) : 3112-3121.
  • 4Sdez B, Martin-Subero JI, Largo C,et al. Identifica- tion of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined Cbanding, spectral karyotyping, and fluorescence in situ hybridization analyses[J]. Cancer Genet Cytogenet, 2006,169(2) : 143-149.
  • 5Lloveras E, Granada I, Zamora L, et al. Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leu- kemia[J]. Cancer Genet Cytogenet, 2004, 148 ( 1 ) : 71-76.
  • 6Mohamed AN, Bentley G, Bunnett ML, et al. Chro- mosome aberrations in a series of 120 multiple mye- loma cases with abnormal karyotypes[J]. Am J He matol, 2007,82 (12) : 1080-1087.
  • 7Smadja NV, Bastard C, Brigaudeau C,et al. Hypo- diploidy is a major prognostic factor in multiple my- eloma[J]. Blood, 2001,98 (7) : 2229-2238.
  • 8Dubinsky R, Amiel A, Manor Y, et al. Fluorescence in situ hybridization (FISH) for retrospective detec- tion of trisomies 3 and 7 in multiple myeloma[J]. Cancer Genetics and Cytogenetics, 1995,83 ( 2 ) : 115- 118.
  • 9苏倩倩,谢晓宝,王志林,邱国强,吴浩清,刘佳,曹祥山.多发性骨髓瘤中14q32易位与13q14缺失的相关性研究[J].白血病.淋巴瘤,2011,20(4):225-228. 被引量:3
  • 10李倩,安刚,李承文,徐燕,邓书会,刘旭平,齐军元,王亚非,邹德慧,赵耀中,邱录贵.染色体13q14缺失在多发性骨髓瘤发生发展中的意义及对其临床预后的影响[J].中华血液学杂志,2011,32(4):217-220. 被引量:10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部